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[ 6 ] The detection of much shorter miRNAs without PCR, however, proved challenging since the method did not have suffi cient target specifi city and binding affi nity. To overcome this problem, we thus combined the use of multivalent labeling with DNA ligation. Target miRNAs in solution were fi rst captured on microbeads and labeled with DNA-modifi ed MNPs. The capture and labeling strands were then enzymatically ligated. By adopting this strategy, we were able to perform robust and selective miRNA detection without nucleotide modifi cation or PCR amplifi cation. Importantly, the assay design was capable of detecting target nucleotides with high specifi city, and could even discriminate closely related miRNAs. To demonstrate the clinical utility of the developed assay, we profi led a series of miRNAs implicated in cardiovascular diseases. With its capacity for point-of-care miRNA detection, this magnetic ligation assay has the potential to have signifi cant clinical applications.
Figure 1 a shows the scheme of the magnetic ligation assay. The method has two main components: i) polymeric beads modifi ed with single-stranded capture probes (either covalently bound or attached via avidin/biotin), and ii) MNPs conjugated to single-stranded labeling probes via a noncleavable heterobifunctional linker. The assay begins by capturing target miRNA strands on microbeads. The unbound portion of the beadimmobilized miRNAs is then labeled with sequence-specifi c MNPs, to create a sandwich nucleotide complex. This is subsequently subjected to ligation and denaturation to improve detection specifi city; namely, samples are treated with Taq DNA Ligase to link the 5′ phosphate terminus of the labeling DNA with the 3′ hydroxyl terminus of the capture DNA, before being incubated under low-salt conditions at 45 °C for denaturation. The level of miRNA expression is then quantifi ed by measuring the R 2 values of samples by NMR.
Initially, we focused on optimizing the assay conditions in order to obtain reliable measurements. The miR-208 family was chosen as the target miRNA, based on its importance in cardiovascular diseases. [ 7, 8 ] Microbeads with a diameter of 1 µm were chosen (see Supporting Information), as they yielded the highest analytical signals while still maintaining colloidal stability (no sedimentation). MNPs used in the assay consisted of a superparamagnetic iron-oxide core (7 nm) and a cross-linked dextran coating, capable of withstanding exposure to variable temperatures, high salt conditions, and reducing agents during the labeling process. [ 9 ] The capture and labeling DNAs were designed to contain a poly(C) spacer, which improved the binding effi ciency by extending the DNA probes from the particle surface. The estimated number of DNA probes per microbead and MNP were 10 5 and 50, respectively. Cross-section Mature microRNAs (miRNAs) are small (typically ≈22 nucleotides) molecules of noncoding RNA that regulate gene expression.
[ 1 ] These molecules form part of the multi-protein RNA-induced silencing complex, which binds to target messenger RNA and inhibits protein translation. Given that deregulated expression levels of distinct miRNAs in tissue or blood samples have been shown to correlate strongly with the status of several human diseases, miRNAs have been highlighted as potential novel diagnostic markers. [ 2 ] However, the clinical application of miRNA analyses has been hindered by their need for extensive and time-consuming sample preparation steps. Namely, due to the inherently low concentration of miRNAs in biological samples, they need to undergo multiple enrichment processes, including total RNA extraction, as well as amplification by polymerase chain reaction (PCR). Furthermore to improve target specifi city, miRNAs need to be elongated prior to PCR (e.g., via poly-A tail elongation or primer ligations). [ 3 ] To exploit the potential of miRNAs in clinical settings, sensitive platforms that can detect miRNAs without complementary DNA (cDNA) synthesis and enzymatic reactions will need to be developed. [ 4 ] We here describe a new magnetic method for fast miRNA detection directly in clinical samples. The approach is based on the self-amplifying effect of magnetic nanoprobes (MNPs) during nuclear magnetic resonance (NMR) measurements. Target nucleotides are fi rst labeled with sequence-specifi c MNPs, which subsequently increases the transverse relaxation rate ( R 2 ) of surrounding water protons. Since a single MNP can affect more than 10 6 surrounding water protons, there is builtin signal amplifi cation, rendering the assay highly sensitive even with small sample volumes. The detection is highly robust against biological backgrounds with minimal need for sample purifi cation. [ 5 ] In previous work, we were successful in applying electron microscopy confi rmed the presence of dense MNPpacking on the bead surface after hybridization (Figure 1 b) ; control beads without the ligation process showed negligible MNP binding ( Figure S1 , Supporting Information).
To increase the number of MNPs on each bead and thereby enhance detection sensitivity, we applied the layer-by-layer assembly approach. [ 10 ] Namely, we designed pairs of MNP conjugates with oligonucleotide sequences that are mutually complementary (see Table S1 , Supporting Information, for the list of oligonucleotides), and added these probes in a sequential, alternating order ( Figure 2 a) . The complementary sets of MNPs were also each modifi ed with different fl uorochromes (VivoTag 680/VT680 and fl uorescein isothiocyanate/FITC) for comparative optical measurements. Figure 2 b shows the fl uorescence analyses confi rming the layer-by-layer probe assembly. After initial labeling with VT680-modifi ed miR-208a-specifi c MNPs, the capture beads displayed far-red fl uorescence. With the formation of a second layer of FITC-modifi ed MNPs, we subsequently observed both far-red and green fl uorescence with fl ow cytometry; fl uorescence micrographs also showed colocalization of both colors on the capture beads. Importantly, such successive layering led to higher R 2 values, and improved overall detection sensitivity (Figure 2 c) . We subsequently performed titration experiments to establish the limit of detection (LOD) for the assay. Samples were prepared by spiking different amounts of miRNAs into a background of total E. coli RNA. We observed a LOD of ≈1 × 10 −12 M miRNAs in 10 µL sample volumes (Figure 2 d) ; the Δ R 2 value of 1 × 10 −12 M miRNA samples was signifi cantly different from that of negative control ( P = 0.0213; two-sided t -test). The high detection sensitivity could be attributed to: 1) the higher binding affi nity of multivalent MNPs ( K D ≈ 56 × 10 −12 M ) compared with individual oligonucleotide strands ( K D ≈ 1.4 × 10 −9 M ); [ 11 ] 2) the amplifying effect of MNPs in NMR detection; 3) the multilayering strategy for maximal MNP loading. The assay assumed a dynamic range of ≈10 3 , and the signal was linear at low miRNA concentrations (1-100 p M ; R 2 = 93%). The assay was also highly reliable. For example, three separate measurements on the same sample yielded statistically identical Δ R 2 values ( P = 0.4643; one-way analysis of variance/ANOVA).
We next assessed the capacity of the magnetic ligation assay to distinguish target miRNA from related nucleic acid strands. This is essential for accurate diagnosis since several miRNAs in a related family can differ by only a few nucleotide bases. To achieve such capability, two key components were incorporated into the developed assay: 1) shorter nucleotide probes that have higher specifi city for their complementary target; and 2) ligation and denaturization processes that minimize offtarget binding. [ 12 ] The shorter nucleotide probes can increase the specifi city for the target strand by decreasing the thermodynamic stability for single-nucleotide mismatch binding. [ 6 ] For this experiment, we designed pairs of probes specifi c for miR-208b ( Figure 3 a) , and then measured the NMR signals after their hybridization with either miR-208a or miR-208b. Upon hybridization with miR-208b, enzymatic ligation resulted in connections between capture strands and adjacent labeling strands; the beads also remained magnetically labeled after the denaturing step. With miR-208a, however, the gap between adjacent probes inhibited enzymatic ligation. Moreover, denaturation of the nucleic acid complex resulted in beads that were no longer magnetically labeled and which displayed R 2 values close to those of buffer solution. We subsequently further expanded the assay to analyze a panel of miRNAs related to cardiovascular diseases. [ 8, 13 ] Accordingly, for a given pair of nucleotide probes, we observed consistent high signals with target miRNA strands (Figure 3 b) . In contrast, with nonspecifi c miRNAs, nucleotide mismatches signifi cantly reduced the hybridization effi ciency, resulting in minimal signals.
We next applied the magnetic ligation assay to the analysis of miRNA in heart tissues, and directly compared our NMR measurements with real-time PCR quantifi cation via the gold standard SYBR Green assay. Accordingly, we found that our NMR measurements showed high expression of miR-208a and miR-1 similar to real-time PCR experiments (Figure 3 c) . In previous studies, it had been reported that both miRNA types are highly expressed in the heart, and that they may thus serve as useful diagnostic biomarkers for cardiovascular diseases. [ 8, 14 ] However, it is important to consider that the current analysis of miRNA levels with NMR measurements are To increase specifi city and minimize off-target binding, Taq DNA Ligase is added to catalyze bond formation between the 5′ phosphate of the labeling DNA and the 3′ hydroxyl of the capture DNA. After removing unbound MNPs, the magnetically labeled beads are inserted into the microcoil for analysis by NMR. Because the R 2 value is proportional to the number of MNPs in the sample, the expression level of miRNAs can be quantifi ed. b) Electron microscopy analysis of the magnetically ligated beads shows dense coverage of MNPs on the bead surface.
wileyonlinelibrary.com 3 COMMUNICATION www.advhealthmat.de primarily qualitative, and our work is currently focused on stringent quantitative assessment for miRNA detection in order to discern differences in expression levels between wild-type and disease phenotypes. Since the current method does not distinguish between precursor, primary, and mature miRNAs, additional work will be conducted to differentiate these strands. Nevertheless, the magnetic ligation assay can be done without reverse transcription and PCR amplifi cation, is faster (60 min) and requires smaller sample volumes (10 µL) than standard techniques.
In summary, magnetic ligation is a promising new method for fast and accurate miRNA analyses. It has the capacity for quantitative miRNA detection without the need for PCR amplifi cation or extensive sample purifi cation steps. Because this novel ligation-denaturation strategy can detect down to single-nucleotide mismatch, it is possible to distinguish target miRNAs from closely related family members. The use of NMR for signal detection enables the assay to be performed with minimal sample purifi cation, minimizing sample loss, and simplifying assay procedures. The assay also benefi ts from fast reaction kinetics, since the signal is detected on a bulk sample. Combined with the miniaturized NMR (µNMR) platform, [ 15 ] which has a small form factor and automatically maintains optimal detection settings, magnetic ligation is a versatile technology for point-of-care diagnosis of various diseases. To increase the sensitivity further and to enable detection of circulating miRNAs in blood (femtomolar to attomolar ranges), we now intend to isolate individual capture beads on femtolitervolume wells to enhance binding effi ciency using lower copy numbers. [ 16 ] In addition, by integrating magnetic ligation with single-bead magnetic detection technology, the sensitivity and sample throughput is expected to increase even further. [ 17 ] Adv. Healthcare Mater. 2014, DOI: 10.1002/adhm.201300672 Table S1 , Supporting Information, for full list of oligonucleotides) were designed for multilayer deposition and for increasing the number of MNPs deposited on the surface. b) Scatter plots from fl ow cytometry measurements are shown for: i) unlabeled beads (left), ii) beads labeled with a single layer of MNPs (middle), and iii) beads labeled with two layers of MNPs (right). Fluorescence microscopy images (inset) are shown for the corresponding beads. c) NMR signals from the beads were measured after each layer of labeling, and normalized with signals from the fi rst layer of labeling. d) The magnetic ligation assay (2 layers of labeling) could detect as low as 10 6 miRNAs in a 10 µL sample containing background E. coli RNA. The µNMR signal values were obtained by normalizing the relaxation rate of samples containing target miRNA with the relaxation rate of control samples. All experiments were performed in triplicate. Figure 3 . Analysis of miRNAs associated with cardiovascular diseases. Enzymatic ligation between the capture and labeling probes was used to detect target miRNAs. a) Nucleotide probe pairs specifi c for miR-208b only ligate in the presence of a fully complementary target. Beads thus remain magnetically labeled even after denaturing the nucleic acid complex. In contrast, because nucleotides between miR-208b probes and miR-208a strands are mismatched, denaturing the nucleic acid complex results in MNP release from the bead surface. b) Relaxation rates for detection of different miRNAs using the magnetic ligation probes. Positive signals only occurred when the capture and labeling probes matched the target miRNA. c) Analysis of a panel of miRNAs related to cardiovascular diseases in human tissue samples. The NMR measurements using the magnetic ligation method were compared with real-time PCR quantifi cation using SYBR Green. All experiments were performed in triplicate.
